Nu se pretează? Nu contează! La noi puteți returna bunurile în 30 de zile
Cu un voucher cadou nu veți da greș. În schimbul voucherului, destinatarul își poate alege orice din oferta noastră.
30 de zile pentru retur bunuri
Myelodysplastic Syndrome (MDS): How common is it? i.e. epidemiology and risk factors.- Therapy related myelodysplasia. Predisposing factors and molecular genetics.- Cytogenetic abnormalities in primary and secondary MDS.- The value of SNP and expression profiling in diagnosis and prognosis.- Molecular pathology of 5q-syndrome and 5q- abnormality.- Genomic instability syndromes and myelodysplasia.- Animal models of myelodysplasia.- Biological defects of haemopoiesis of low risk MDS.- Prognostic evaulation of primary MDS.- FAB, WHO, IWG and beyond.- Methylation and histone acetylation in the context of MDS.- Treatment of MDS with demethylating agents and HDAC inhibitor.- Supportive treatment in low and high risk MDS.- Allogeneic stem cell transplantation in MDS.- Immune dysregulation and immunosuppressive therapy MDS.- Aplastic anaemia/MDS overlap syndrome.- Clinical and molecular spectrum of Myeloproliferative/Myelodysplastic disorders (MPD/MDS).- MPD/MDS overlap syndromes.- Adult and juvenile Chronic Myelomonocytic Leukemia (CMML.- Emerging therapies including Lenolidamide